Green synthesized plant mediated zinc oxide nanoparticles as potential nano phytotherapeutic agents for reactive oxygen species driven anticancer activity in HepG2 liver cancer cells
6 affiliations
- 1Department of Chemistry & Sustainability, School of Basic Sciences, Galgotias University
- 2School of Pharmacy, Sharda University
- 3School of Chemical Sciences, Universiti Sains Malaysia
- 4Department of Chemistry, College of Science, King Saud University
- 5Faculty of Applied Sciences and Biotechnology, Shoolini University
- 6Department of Medical Research, China Medical University Hospital, China Medical University
Abstract
Green nanotechnology has emerged as a promising approach for the sustainable synthesis of metal oxide nanoparticles with potential applications in cancer therapy. In this study, aqueous extracts of Galinsoga parviflora (GP), Ageratum conyzoides (AC), and Argemone mexicana (AM) were employed as green agents for the biosynthesis of zinc oxide nanoparticles (ZnO-NPs). Characterization confirmed the formation of phase-pure, crystalline ZnO-NPs with a hexagonal wurtzite structure and predominantly spherical morphology. The mean particle sizes were 12.33 ± 5.58 nm (GP-ZnO), 12.05 ± 4.51 nm (AM-ZnO), and 10.32 ± 1.98 nm (AC-ZnO), with the overall observed size range of 5–36 nm. Zeta potentials ranging from −8.2 to −8.6 mV indicated weak electrostatic stabilization and a tendency for some aggregation, as observed in FE-SEM images. FT-IR confirmed ZnO formation with residual surface-associated plant-derived constituents, while XRD exhibited characteristic reflections corresponding to the (100), (002), (101), (102), (103), (110), and (112) crystal planes of wurtzite ZnO. The biosynthesized ZnO-NPs demonstrated favorable biocompatibility, exhibiting minimal haemolysis and negligible cytotoxicity against normal THLE-2 liver cells. GP-ZnO, AM-ZnO, and AC-ZnO-NPs exhibited concentration-dependent cytotoxicity against HepG2 carcinoma cells, with IC ₅₀ values of 60.25 ± 3.2, 68.35 ± 3.4, and 74.15 ± 2.6 μg/mL, respectively. Treatment markedly enhanced intracellular ROS and Annexin V ⁺ cells, with GP-ZnO and AM-ZnO-NPs inducing 59.71% and 57.40% Annexin V ⁺ cells, respectively, against 50.05% for Doxorubicin (Dox). Despite lower ROS levels than Dox, their higher apoptotic fractions suggest ROS-independent mechanisms may contribute to cytotoxicity. However, lack of PI staining prevented differentiation between late apoptosis and necrosis. Overall, plant-mediated ZnO-NPs show promise as sustainable candidates for further in vivo investigation and translational development in liver cancer nanotherapy.
Related
- Nephroprotective and Gastroprotective potential of Aerva javanica (L.) green synthesized nanoparticles, supported by Molecular Networking
- Nutraceutical, Nutritional and Phytotherapeutic Interventions for Neuropsychiatric Disorders Associated with Intellectual Disability: Mechanisms and Clinical Evidence
- Metal-dependent Structure, Solution Properties, and Redox-Mediated Anticancer Activity of Rhodium(III) and Iridium(III) Half-Sandwich Phenanthroline-Sulfonamide Complexes.
- Identification of novel compounds from Olea Europaea targeting hDus2 as potential anticancer agents: a molecular docking and molecular dynamics study
- Development and Characterization of Phlomis brachyodon Extract-Loaded Thermoresponsive In Situ Gels: Antioxidant Activity, Wound-Healing Evaluation in a Rat Excision Model, and Potential Anticancer Activity.
BibTeX
@article{sharma2026green,
title = {{Green synthesized plant mediated zinc oxide nanoparticles as potential nano phytotherapeutic agents for reactive oxygen species driven anticancer activity in HepG2 liver cancer cells}},
author = {Anupama Sharma and Lalit Prasad and Sandeep Kumar and Khalid Umar and Mohd Sajid Ali and Sadanand Pandey},
journal = {Frontiers in Oncology},
year = {2026},
month = oct,
doi = {10.3389/fonc.2026.1832928},
url = {https://www.frontiersin.org/articles/10.3389/fonc.2026.1832928/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Green synthesized plant mediated zinc oxide nanoparticles as potential nano phytotherapeutic agents for reactive oxygen species driven anticancer activity in HepG2 liver cancer cells
AU - Anupama Sharma
AU - Lalit Prasad
AU - Sandeep Kumar
AU - Khalid Umar
AU - Mohd Sajid Ali
AU - Sadanand Pandey
PY - 2026
DA - 2026/10/29
JO - Frontiers in Oncology
DO - 10.3389/fonc.2026.1832928
UR - https://www.frontiersin.org/articles/10.3389/fonc.2026.1832928/full
AB - Green nanotechnology has emerged as a promising approach for the sustainable synthesis of metal oxide nanoparticles with potential applications in cancer therapy. In this study, aqueous extracts of Galinsoga parviflora (GP), Ageratum conyzoides (AC), and Argemone mexicana (AM) were employed as green agents for the biosynthesis of zinc oxide nanoparticles (ZnO-NPs). Characterization confirmed the formation of phase-pure, crystalline ZnO-NPs with a hexagonal wurtzite structure and predominantly spherical morphology. The mean particle sizes were 12.33 ± 5.58 nm (GP-ZnO), 12.05 ± 4.51 nm (AM-ZnO), and 10.32 ± 1.98 nm (AC-ZnO), with the overall observed size range of 5–36 nm. Zeta potentials ranging from −8.2 to −8.6 mV indicated weak electrostatic stabilization and a tendency for some aggregation, as observed in FE-SEM images. FT-IR confirmed ZnO formation with residual surface-associated plant-derived constituents, while XRD exhibited characteristic reflections corresponding to the (100), (002), (101), (102), (103), (110), and (112) crystal planes of wurtzite ZnO. The biosynthesized ZnO-NPs demonstrated favorable biocompatibility, exhibiting minimal haemolysis and negligible cytotoxicity against normal THLE-2 liver cells. GP-ZnO, AM-ZnO, and AC-ZnO-NPs exhibited concentration-dependent cytotoxicity against HepG2 carcinoma cells, with IC ₅₀ values of 60.25 ± 3.2, 68.35 ± 3.4, and 74.15 ± 2.6 μg/mL, respectively. Treatment markedly enhanced intracellular ROS and Annexin V ⁺ cells, with GP-ZnO and AM-ZnO-NPs inducing 59.71% and 57.40% Annexin V ⁺ cells, respectively, against 50.05% for Doxorubicin (Dox). Despite lower ROS levels than Dox, their higher apoptotic fractions suggest ROS-independent mechanisms may contribute to cytotoxicity. However, lack of PI staining prevented differentiation between late apoptosis and necrosis. Overall, plant-mediated ZnO-NPs show promise as sustainable candidates for further in vivo investigation and translational development in liver cancer nanotherapy.
SN - 2234-943X
ER -